Cargando…
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445335/ https://www.ncbi.nlm.nih.gov/pubmed/33608230 http://dx.doi.org/10.1016/j.molmed.2021.01.004 |
| _version_ | 1784568633041616896 |
|---|---|
| author | Bar-Or, Amit Pender, Michael P. Khanna, Rajiv Steinman, Lawrence Hartung, Hans-Peter Maniar, Tap Croze, Ed Aftab, Blake T. Giovannoni, Gavin Joshi, Manher A. |
| author_facet | Bar-Or, Amit Pender, Michael P. Khanna, Rajiv Steinman, Lawrence Hartung, Hans-Peter Maniar, Tap Croze, Ed Aftab, Blake T. Giovannoni, Gavin Joshi, Manher A. |
| author_sort | Bar-Or, Amit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8445335 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84453352021-09-16 Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020) Bar-Or, Amit Pender, Michael P. Khanna, Rajiv Steinman, Lawrence Hartung, Hans-Peter Maniar, Tap Croze, Ed Aftab, Blake T. Giovannoni, Gavin Joshi, Manher A. Trends Mol Med Correction The Author(s). Published by Elsevier Ltd. 2021-04 2021-02-17 /pmc/articles/PMC8445335/ /pubmed/33608230 http://dx.doi.org/10.1016/j.molmed.2021.01.004 Text en © 2018 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correction Bar-Or, Amit Pender, Michael P. Khanna, Rajiv Steinman, Lawrence Hartung, Hans-Peter Maniar, Tap Croze, Ed Aftab, Blake T. Giovannoni, Gavin Joshi, Manher A. Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020) |
| title | Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020) |
| title_full | Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020) |
| title_fullStr | Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020) |
| title_full_unstemmed | Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020) |
| title_short | Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020) |
| title_sort | epstein–barr virus in multiple sclerosis: theory and emerging immunotherapies: (trends in molecular medicine, 26:3 p:296-310, 2020) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445335/ https://www.ncbi.nlm.nih.gov/pubmed/33608230 http://dx.doi.org/10.1016/j.molmed.2021.01.004 |
| work_keys_str_mv | AT baroramit epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 AT pendermichaelp epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 AT khannarajiv epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 AT steinmanlawrence epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 AT hartunghanspeter epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 AT maniartap epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 AT crozeed epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 AT aftabblaket epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 AT giovannonigavin epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 AT joshimanhera epsteinbarrvirusinmultiplesclerosistheoryandemergingimmunotherapiestrendsinmolecularmedicine263p2963102020 |